SMAD1 and breast carcinoma: To characterise the BMP4 responses, we predominantly used the human breast cancer cell line MDA-MB-231 and the mouse fibroblast cell line NIH-3T3, both of which induce robust SMAD1/5 phosphorylation in response to BMP4.